Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids-Reference-Cited by-同舟云学术

Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids

Published:2013-09 Issue:3 Volume:132 Page:567-574.e12
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Noonan Michael,Korenblat Phillip,Mosesova Sofia,Scheerens Heleen,Arron Joseph R.,Zheng Yanan,Putnam Wendy S.,Parsey Merdad V.,Bohen Sean P.,Matthews John G.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference20 articles.

1. Clinical phenotypes of asthma;Bel;Curr Opin Pulm Med,2004

2. Cluster analysis and clinical asthma phenotypes;Haldar;Am J Respir Crit Care Med,2008

3. Asthma: defining of the persistent adult phenotypes;Wenzel;Lancet,2006

4. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma;Humbert;J Allergy Clin Immunol,1997

5. Requirement for IL-13 independently of IL-4 in experimental asthma;Grunig;Science,1998

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal antibodies for moderate-to-severe atopic dermatitis: a look at phase III and beyond;Expert Opinion on Biological Therapy;2024-06-02

2. CCL13 and human diseases;Frontiers in Immunology;2023-04-19

3. The clinical efficacy of type 2 monoclonal antibodies in eosinophil-associated chronic airway diseases: a meta-analysis;Frontiers in Immunology;2023-04-11

4. Targeting Interleukin 13 for the Treatment of Atopic Dermatitis;Pharmaceutics;2023-02-08

5. Serum Interleukin-33 and Soluble Suppression of Tumorigenicity 2 in Bronchial Asthma;The Indian Journal of Chest Diseases and Allied Sciences;2022-11-18